A device for easing migraine pain, renovated veterans housing in Florida and an 100-year-old former Rosie the Riveter, Irene ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
Despite mixed results from its experimental schizophrenia treatment last month, MapLight Therapeutics is going all-in on the asset—at the expense of its preclinical programs. In its second-quarter ...
Businesses in the health and wellness industry are getting a boost, thanks to off-label usage and doctor’s orders.
TONMYA® net sales totaled approximately $11 million, an increase of 197% quarter-over-quarter Commercial and government payer coverage for ...
Adolescents and young adults with chronic migraines saw significant reductions in daily headaches and in headache disability scores after treatments of onabotulinumtoxin A, according to data published ...
FLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be ...
Migraine Again on MSN
Could this new pain drug provide migraine relief? What to know about suzetrigine (Journavx)
Can suzetrigine (Journavx) help with migraine pain? Learn how this new nonopioid pain drug works off-label, what the research ...
As generative AI captures public attention, a different kind of AI is reshaping drug discovery. Machine learning models are helping to compress decade-long timelines and cracking problems that were ...
OMAHA, Neb. (WOWT) - The Fred and Pamela Buffett Cancer Center is now enrolling patients in an expanded access program for daraxonrasib, an investigational drug that targets a gene mutation found in ...
Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results